Content about Johnson & Johnson

January 26, 2012
Pfizer, J&J subsidiary, charity group launch Alzheimer's Challenge 2012

Pfizer is partnering with a division of Johnson & Johnson and a charity organization to launch an initiative to award funding to projects designed to improve the diagnostic identification and tracking of Alzheimer's disease.

January 25, 2012
McNeil Consumer to make marketing splash as OTC brands return to market

Johnson & Johnson is preparing to turn the corner with its McNeil Consumer Healthcare business, J&J chairman and CEO William Weldon told analysts during the company's fourth-quarter earnings call Tuesday.

January 10, 2012
Shire acquires U.S. rights to constipation drug

Shire has acquired U.S. rights to a drug used to treat chronic constipation in women from Johnson & Johnson, the company said Tuesday.

December 22, 2011
McNeil recalls Motrin tablets for reduction in efficacy nearing expiration dates

McNeil Consumer Healthcare on Wednesday issued a voluntarily recall of certain lots of Motrin IB coated tablets from retailers.

December 20, 2011
Ulcerative colitis market to hit $3 billion by 2020

The market for drugs to treat ulcerative colitis will increase from 2010's $1.7 billion to $3 billion in 2020, according to a new report by market research firm Decision Resources.

December 14, 2011
Report: J&J names new top marketing executive

Johnson & Johnson recently named Michael Sneed to oversee its global marketing and public relations functions, according to a report published Tuesday on AdAge.com, effective Jan. 1.

December 13, 2011
FTC approves Valeant's acquisitions of Dermik, Ortho Dermatologics

The Federal Trade Commission has voted to approve Valeant's acquisitions of Dermik, a unit of French drug maker Sanofi that makes drugs for skin conditions, and Ortho Dermatologics, a division of Johnson & Johnson that also makes skin drugs.

November 7, 2011
FDA approves J&J's Xarelto for stroke prevention

The Food and Drug Administration has approved a drug made by Johnson & Johnson for preventing stroke in patients with abnormal heart rhythm, the agency said.

November 4, 2011
Branded generics offer new ways to reformulate drugs

In the classic “Arabian Nights” tale of Aladdin and his magic lamp, the evil sorcerer who made Aladdin retrieve the lamp containing the genie attempts to get it back by tricking Aladdin’s wife into giving it to him by roaming through the streets offering to trade “new lamps for old.”


November 2, 2011
J&J Campaign for Nursing's Future hosts gala to raise funds to help ease nursing shortage in S.C.

The Johnson & Johnson Campaign for Nursing's Future will host the Promise of Nursing for South Carolina gala to raise funds and provide scholarships to help ease the nursing shortage in South Carolina.

November 1, 2011
Rite Aid, LifeScan officially kick off Rite Track Diabetes Tour

Rite Aid and LifeScan kicked off the Rite Track Diabetes Tour in New York on Tuesday with a special appearance by celebrity chef Sam Talbot.

October 31, 2011
J&J submits new FDA application for Nucynta ER

A Johnson & Johnson subsidiary has sent a regulatory application to the Food and Drug Administration seeking approval for one of its drugs in treating diabetes-related pain.

October 18, 2011
J&J pledges to recapture luster of McNeil OTC brands

Johnson & Johnson Tuesday morning pledged significant support behind the relaunch of several McNeil Consumer products into the marketplace in 2012, and feels confident impacted brands — Tylenol and Motrin, among others — will be able to recapture market share, despite significant private-label erosion.

September 29, 2011
J&J/Merck Consumer now officially part of McNeil

McNeil-PPC announced Wednesday that the acquisition of full ownership of the Johnson & Johnson-Merck Consumer Pharmaceuticals joint venture has been completed.

September 26, 2011
FDA approves Remicade for ulcerative colitis in children

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis in children.

September 26, 2011
Tylenol slugger expected to knock 'em out of the park this season

With Tylenol coming back to cough-cold and analgesic aisles over the next six months, you can bet the brand will soon resume its status as the cleanup hitter for Team OTC. That not only means a reshuffling of the lineup, but the respective No. 9 hitters will be packing their bags for a trip back to the minors.

September 22, 2011
J&J HIV drug shows fewer side effects in trial data analysis

A new study has found that a recently approved drug for HIV produces fewer unpleasant side effects during the first three months of therapy than the standard treatment, according to published reports.

September 22, 2011
Report: J&J resumes shipping of Tylenol product

It seems that Tylenol Cold & Flu Severe caplets are making their way back to store shelves, according to published reports.

September 15, 2011
LifeScan introduces talking glucose meter in India

LifeScan on Thursday kicked off the global launch of its new blood-glucose monitoring device specifically designed to make self-monitoring simple.

August 26, 2011
J&J drug approved for chronic pain

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating chronic pain, a J&J subsidiary said Friday.

August 18, 2011
J&J adds pain drug resources to responsible prescribing site

Johnson & Johnson has launched several new tools on a website aimed at ensuring patients with pain get the drugs they need while staying safe.

August 11, 2011
FDA approves single-pill HIV drug

The Food and Drug Administration has approved a new single-pill treatment for HIV made by Gilead Sciences and Johnson & Johnson, Gilead said.

August 9, 2011
GSK names new chief marketing officer

GlaxoSmithKline Consumer Healthcare on Monday named John Graham chief marketing officer for Consumer Healthcare, North America.

August 4, 2011
J&J rings in 125th year with NYSE

Johnson & Johnson chairman and CEO Bill Weldon on Wednesday morning rang the NYSE opening bell remotely from Johnson & Johnson world headquarters here as part of the company's employee celebration of its 125th anniversary.

July 29, 2011
Hi-Tech Pharmacal introduces generic Levaquin

A generic version of a popular pneumonia treatment has entered the market from Hi-Tech Pharmacal.

© 2013 Drug Store News. All Rights Reserved.